Ethypharm to borrow €285m for DB Ashbourne acquisition
Ethypharm, the French pharmaceutical company, is holding a bank meeting today (October 26) for €285.5m of new debt to finance the acquisition of DB Ashbourne, the UK branded drugs firm.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts